Skip to main content
. Author manuscript; available in PMC: 2021 Jan 1.
Published in final edited form as: Biochim Biophys Acta Mol Basis Dis. 2019 Oct 19;1866(1):165561. doi: 10.1016/j.bbadis.2019.165561

Fig. 2. RAD6 inhibition enhances cisplatin (CDDP) sensitivities of BRCA1 wild-type and mutant TNBC cells in vitro.

Fig. 2.

MTT assays of MDA-MB-468 (A), HCC1937 (B), SUM1315 (C) cells. Data are mean ± S.D. of three independent experiments. (D) Clonogenic assay. SUM1315 cells were treated overnight with SMI#9 (3 μM), CDDP (1 μM), or with a combination of SMI#9 and CDDP. Cells were trypsinized and reseeded in quadruplicates at 100 cells per well. Results are mean ± S.D. percent colony formation efficiency from two independent experiments. *Indicates P < .01.